$SPRO Spero Therapeutics, Inc. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Spero Therapeutics, Inc..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in Spero Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Spero Therapeutics, Inc. for free.

CIK Number: 0001701108
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SPRO
Company Address: 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE 02139
Phone number: 857-242-1600
Former name: Spero Therapeutics, LLC, date of change: 2017-03-16

Spero Therapeutics, Inc. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 10 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS21.743,00065,2153,829,2093.8 M to 3.8 M (-0.08 %)
Feb 04 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.9934,144648,2553,832,2093.9 M to 3.8 M (-0.88 %)
Feb 04 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.9829,354557,1013,866,3533.9 M to 3.9 M (-0.75 %)
Feb 04 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.9922,841433,7713,895,7073.9 M to 3.9 M (-0.58 %)
Feb 04 2021SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS19.2413,661262,8613,918,5483.9 M to 3.9 M (-0.35 %)
Feb 03 2021SPROSpero Therapeutics ...Keutzer TimothyChief Development O ...Option ExerciseA19.1857,4321,101,54657,432
Feb 03 2021SPROSpero Therapeutics ...Larkin CristinaChief Operating Off ...Option ExerciseA19.1857,4321,101,54657,432
Feb 03 2021SPROSpero Therapeutics ...Mahadevia AnkitSee RemarksOption ExerciseA19.18179,3193,439,338179,319
Feb 03 2021SPROSpero Therapeutics ...Melnick David A.Chief Medical Offic ...Option ExerciseA19.1857,4321,101,54657,432
Jan 06 2021SPROSpero Therapeutics ...Smith CynthiaDirectorOption ExerciseA17.932,62947,1382,629
Jan 06 2021SPROSpero Therapeutics ...THOMAS FRANK EDirectorOption ExerciseA17.931,31423,5601,314
Jan 06 2021SPROSpero Therapeutics ...Deshpande MilindDirectorOption ExerciseA17.932,62947,1382,629
Dec 18 2020SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.81250,0004,703,2253,932,2094.2 M to 3.9 M (-5.98 %)
Dec 18 2020SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS18.6214,933278,0354,182,2094.2 M to 4.2 M (-0.36 %)
Nov 10 2020SPROSpero Therapeutics ...Aquilo Capital Management, LLC10% OwnerSellS13.77125,9001,734,0714,197,1424.3 M to 4.2 M (-2.91 %)

View all Spero Therapeutics, Inc. insider transactions.